HISCO: new drug application for innovative drug hsk31858 tablets accepted
Financial Associated Press, Nov. 29 - HISCO announced that it had obtained the acceptance notice of new drug application for innovative drug hsk31858. Hsk31858 tablets are intended to treat lower respiratory tract diseases caused by bronchiectasis and acute lung injury / acute respiratory distress syndrome.
This text is a result of machine translation.
Briefing Dec 19, 2023 10:56 AM
EcoFlow Fined 100 Million Euros from EU, Sources Say
In-depth
Briefing Oct 20, 2023 06:03 PM
· Technology
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
May 11, 2023 05:07 PM
Jan 06, 2023 08:30 AM
Briefing Oct 18, 2023 07:02 PM
UAE Bets Big on Renewable Energy, Expects to Invest Over USD 160 Billion in Next 30 Years
Briefing Oct 18, 2023 07:01 PM
Wind Power is Propelled into a New Phase of Extraordinary Growth
Briefing Oct 08, 2023 06:27 PM
Shenzhen Sets Ambitious Goals for Green and Innovative Industries: Aiming for CNY 100 Billion in New Energy Industry Value
Briefing Oct 08, 2023 06:20 PM
Shenzhen Targets 1 Million Kilowatts of Virtual Power Plant Load Regulation by 2025
Briefing Oct 08, 2023 06:15 PM
Shenzhen Accelerates Drive Towards Green Construction: Over 100 Projects to Join Smart Construction Pilot by 2025
Briefing Sep 26, 2023 06:28 PM
SPIC Smart Energy Corporation and Tencent Cloud Officially Signs a Strategic Cooperation Agreement
Briefing Sep 26, 2023 06:27 PM
SVOLT is Poised to Ship 1.6 Million Units Domestically this Year
Briefing Sep 20, 2023 12:51 PM
Chinese Insurtech QingSong Health Marks 9th Anniversary with Bold Steps Towards a Healthier China
Briefing Sep 18, 2023 07:40 PM
· Technology
4Paradigm Initiates IPO Today and Targets HKSE on September 28
Briefing Sep 18, 2023 07:38 PM
· Automotive
Electric Vehicles to Account for Two-thirds of Global Vehicle Sales by 2030
See more
Read next
Insight
In-depth
Insight
In-depth